Bunavail FDA Approval History
Last updated by Judith Stewart, BPharm on Jan 28, 2021.
FDA Approved: Yes (Discontinued) (First approved June 6, 2014)
Brand name: Bunavail
Generic name: buprenorphine and naloxone
Dosage form: Buccal Film
Company: BioDelivery Sciences International, Inc.
Treatment for: Opioid Use Disorder
Bunavail (buprenorphine and naloxone) buccal film is an opioid analgesic/opioid antagonist formulation for the maintenance treatment of opioid dependence.
Development timeline for Bunavail
| Date | Article |
|---|---|
| Jun 9, 2014 | Approval FDA Approves Bunavail Buccal Film for the Maintenance Treatment of Opioid Dependence |
| Oct 14, 2013 | BioDelivery Sciences Announces FDA Acceptance of Bunavail NDA for Filing |
Further information
Always consult your healthcare provider to ensure the information displayed on this page applies to your personal circumstances.
